Owners, management and financials
CVR: 20826746
Secondary names: LØNDAL PREPRESS A/S
Previous names: LØNDAL PREPRESS A/S
DKK 48,337,049
Gross profit
Net result: DKK 12,305,927
FPIH HOLDING ApS (100%)
CVR · view owners
Flemming Sten Pedersen
Board: 3 members
CVR · view management
Active
Founded 31 March 1998
CVR · view overview
36 employees
CVR · 2026
Name registered: PHARMA TECHNOLOGY A/S
CVR · 29/09/2005
View the full event history
PHARMA TECHNOLOGY A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1998. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The company was previously named LØNDAL PREPRESS A/S. The management consists of Flemming Sten Pedersen. The board consists of Flemming Sten Pedersen, Inge Holsted Hansen and Svenn Ryberg Hansen. The company is owned by FPIH HOLDING ApS. The company has 36 employees (2026). In 2025, the company reported a gross profit of DKK 48,337,049 and a net result of DKK 12,305,927 compared with DKK 9,046,574 the year before. Equity in the 2025 report amounted to DKK 12,805,927.
Source: annual report 2025, Danish Business Authority
The financial health of PHARMA TECHNOLOGY A/S appears robust, with a consistent upward trend in gross profit and profit over the past five years. Gross profit increased from 19.15 million DKK in 2021 to 48.34 million DKK in 2025, while profit rose from 7.62 million DKK to 12.31 million DKK in the same period, indicating strong operational efficiency and profitability. The company's equity has also grown significantly, reaching 12.81 million DKK in 2025, which reflects a solid capital position. However, the lack of disclosed revenue figures may raise concerns about transparency and overall market positioning within the engineering consulting sector. Overall, the company demonstrates strong financial performance, but its undisclosed revenue could be a potential area for scrutiny.
AI-generated summary · Generated 15/08/2026
Selskabets formål er: at udføre konsulentassistance m.v.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | 12.3 mio. | 34.1 mio. | 12.8 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | - | 9 mio. | 26.2 mio. | 9.5 mio. | 24 | |
| 202301/01/2023 – 31/12/2023 | - | 10.1 mio. | 24 mio. | 10.6 mio. | 15 | |
| 202201/01/2022 – 31/12/2022 | - | 7.1 mio. | 21 mio. | 7.6 mio. | 11 | |
| 202101/01/2021 – 31/12/2021 | - | 7.6 mio. | 18.7 mio. | 8.1 mio. | 11 | |
| 202001/01/2020 – 31/12/2020 | - | 6.3 mio. | 18.9 mio. | 6.8 mio. | 8 | |
| 201901/01/2019 – 31/12/2019 | - | 3.7 mio. | 13.5 mio. | 4.2 mio. | 6 | |
| 201801/01/2018 – 31/12/2018 | - | 3.5 mio. | 8.1 mio. | 4 mio. | - | |
| 201701/01/2017 – 31/12/2017 | - | 5.3 mio. | 10.1 mio. | 5.8 mio. | - | |
| 201601/01/2016 – 31/12/2016 | - | 5.5 mio. | 13 mio. | 6.6 mio. | 11 | |
| 201501/01/2015 – 31/12/2015 | - | 3.7 mio. | 7.9 mio. | 4.8 mio. | 9 | |
| 201401/01/2014 – 31/12/2014 | 24.5 mio. | 4.6 mio. | 9.3 mio. | 5.1 mio. | 11 | |
| 201301/01/2013 – 31/12/2013 | - | 3.6 mio. | 10.6 mio. | 4.1 mio. | - | |
| 201201/01/2012 – 31/12/2012 | - | 1.4 mio. | 5.1 mio. | 1.9 mio. | - |
Compared to 1.020 companies in Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of PHARMA TECHNOLOGY A/S is 20826746.
PHARMA TECHNOLOGY A/S is owned by FPIH HOLDING ApS.
The management of PHARMA TECHNOLOGY A/S consists of Flemming Sten Pedersen.
The board of PHARMA TECHNOLOGY A/S consists of Flemming Sten Pedersen, Inge Holsted Hansen and Svenn Ryberg Hansen.
In 2025, PHARMA TECHNOLOGY A/S reported a gross profit of DKK 48,337,049.
PHARMA TECHNOLOGY A/S had 36 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
PHARMA TECHNOLOGY A/S has published its annual report for 2025. Gross profit came to DKK 48,337,049, and the net result was DKK 12,305,927.
PHARMA TECHNOLOGY A/S has published its annual report for 2024. Gross profit came to DKK 34,739,215, and the net result was DKK 9,046,574.
PHARMA TECHNOLOGY A/S has published its annual report for 2023. Gross profit came to DKK 28,277,404, and the net result was DKK 10,069,643.
PHARMA TECHNOLOGY A/S has published its annual report for 2022. Gross profit came to DKK 20,334,078, and the net result was DKK 7,100,737.
PHARMA TECHNOLOGY A/S has published its annual report for 2021. Gross profit came to DKK 19,151,464, and the net result was DKK 7,621,354.
PHARMA TECHNOLOGY A/S has published its annual report for 2020. Gross profit came to DKK 13,926,306, and the net result was DKK 6,301,467.
PHARMA TECHNOLOGY A/S has published its annual report for 2019. Gross profit came to DKK 9,322,886, and the net result was DKK 3,729,246.
PHARMA TECHNOLOGY A/S has published its annual report for 2018. Gross profit came to DKK 10,929,583, and the net result was DKK 3,536,660.
PHARMA TECHNOLOGY A/S has published its annual report for 2017. Gross profit came to DKK 16,233,914, and the net result was DKK 5,320,056.
As of March 19, 2018, Revisionskontoret i Faxe has been appointed auditor of PHARMA TECHNOLOGY A/S.
As of March 19, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of PHARMA TECHNOLOGY A/S.
PHARMA TECHNOLOGY A/S has published its annual report for 2016. Gross profit came to DKK 18,518,946, and the net result was DKK 5,518,604.
PHARMA TECHNOLOGY A/S has published its annual report for 2015. Gross profit came to DKK 10,571,562, and the net result was DKK 3,721,503.
PHARMA TECHNOLOGY A/S has published its annual report for 2014. Revenue came to DKK 24,461,556, and the net result was DKK 4,567,583.
PHARMA TECHNOLOGY A/S has published its annual report for 2013. Gross profit came to DKK 12,826,166, and the net result was DKK 3,566,626.
As of May 21, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PHARMA TECHNOLOGY A/S.
As of May 21, 2014, Revisionsfirmaet Tom Sønderup I/S has stepped down as auditor of PHARMA TECHNOLOGY A/S.
PHARMA TECHNOLOGY A/S has published its annual report for 2012. Gross profit came to DKK 5,987,257, and the net result was DKK 1,428,526.
As of May 8, 2012, Inge Holsted Hansen has joined the board of directors of PHARMA TECHNOLOGY A/S.
As of May 8, 2012, Bjarne Grølsted-Kristensen has left the board of directors of PHARMA TECHNOLOGY A/S.
As of May 15, 2009, Revisionsfirmaet Tom Sønderup I/S has been appointed auditor of PHARMA TECHNOLOGY A/S.
As of May 15, 2009, A/S PSE NR. 4820 has stepped down as auditor of PHARMA TECHNOLOGY A/S.
As of March 6, 2006, A/S PSE NR. 4820 has been appointed auditor of PHARMA TECHNOLOGY A/S.
As of March 6, 2006, Pricewaterhouse Coopers has stepped down as auditor of PHARMA TECHNOLOGY A/S.
As of September 29, 2005, Claus Løndal Nielsen has left the board of directors of PHARMA TECHNOLOGY A/S.
On September 29, 2005, the company changed its name from LØNDAL PREPRESS A/S to PHARMA TECHNOLOGY A/S.
As of October 1, 2003, FPIH HOLDING ApS is registered as an owner of PHARMA TECHNOLOGY A/S with an ownership share of 100%.
As of May 28, 2003, Bjarne Grølsted-Kristensen has joined the board of directors of PHARMA TECHNOLOGY A/S.
As of June 28, 2000, ALBERT PEDERSEN. STATSAUTORISEREDEREVISORER I/S has stepped down as auditor of PHARMA TECHNOLOGY A/S.
As of May 15, 2000, Pricewaterhouse Coopers has been appointed auditor of PHARMA TECHNOLOGY A/S.
As of August 6, 1998, Svenn Ryberg Hansen has joined the board of directors of PHARMA TECHNOLOGY A/S.
As of August 6, 1998, Allan Weimar Andersen has left the board of directors of PHARMA TECHNOLOGY A/S.
As of March 31, 1998, ALBERT PEDERSEN. STATSAUTORISEREDEREVISORER I/S has been appointed auditor of PHARMA TECHNOLOGY A/S.
As of March 31, 1998, Claus Løndal Nielsen has joined the board of directors of PHARMA TECHNOLOGY A/S.
As of March 31, 1998, Flemming Sten Pedersen has joined the board of directors of PHARMA TECHNOLOGY A/S.
As of March 31, 1998, Allan Weimar Andersen has joined the board of directors of PHARMA TECHNOLOGY A/S.
As of March 31, 1998, Flemming Sten Pedersen is registered as director of PHARMA TECHNOLOGY A/S.
PHARMA TECHNOLOGY A/S was founded on March 31, 1998.
At Copenhagen Wine, we are deeply committed to wine and love to share our passion with you. You are invited into our world of wine, where each bottle comes with a story, and where you will find carefully selected wines from producers with whom we have an in-depth knowledge and a close relationship. We ensure you the best experiences in the beautiful world of wine.
Selskabets formål er at drive virksomhed med handel og service, samt enhver i forbindelse hermed stående virksomhed.
Companies in the same industry and area
CVR 27165052
CVR 29143560
CVR 30814134
CVR 46133579
CVR 46179048
